Annual Drug Patent Expirations for CABENUVA+KIT
Cabenuva Kit is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
Drug patent litigation for CABENUVA KIT.
This drug has three hundred and thirty-eight patent family members in forty-nine countries.
The generic ingredient in CABENUVA KIT is cabotegravir; rilpivirine. One supplier is listed for this compound. Additional details are available on the cabotegravir; rilpivirine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
